Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020

BACKGROUND: We analyzed the attainment of early pharmacological targets of continuous infusion meropenem and piperacillin/tazobactam and the use and effect of a real-time therapeutic drug monitoring (TDM) program on subsequent dosing and target attainment in patients who are critically ill. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Dräger, Sarah, von Rotz, Matthias, Labhardt, Niklaus D, Siegemund, Martin, Rentsch, Katharina M, Osthoff, Michael, Franzeck, Fabian C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109529/
https://www.ncbi.nlm.nih.gov/pubmed/37077503
http://dx.doi.org/10.1093/ofid/ofad143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109529/
https://www.ncbi.nlm.nih.gov/pubmed/37077503
http://dx.doi.org/10.1093/ofid/ofad143

Ejemplares similares